PBSS Small Molecule Preclinical Dev 26
Date: April 17, 2026
Location: San Francisco, California
JOIN US!
Come meet us at PBSS on April 17 to explore how Catalent’s integrated macromolecule and small molecule capabilities can accelerate your development programs. Learn how our end‑to‑end expertise helps de‑risk, optimize, and advance molecules from early phase to clinic and beyond.
Complete the form to schedule a meeting with our experts!
SPEAKING ENGAGEMENTS
Speaker: Nathan Bennette, Director, Scientific and Technical Advisory
Date/Time: 17th April 2026
Title: Formulation Challenges: Know What Problem You’re Trying to Solve
NETWORKING EVENTS!
Don’t miss to connect with our experts at the PBSS lunch reception sponsored by Catalent on April 17 to learn more about our macromolecule and small molecule capabilities.
ABOUT CATALENT
Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at nearly 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.
